Active, not recruiting |
: Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Fallopian Tube Clear Cell Adenocarcinoma
- Fallopian Tube Endometrioid Adenocarcinoma
: 2010-02-23
: - Drug: Bortezomib Given IP
|
Terminated |
: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Clear Cell Cystadenoc
: 2000-01-28
: - Drug: Carboplatin Given IV
|
Completed |
: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
: - Brenner Tumor
- Ovarian Clear Cell Cystadenocarcinoma
: 1999-11-01
: - Drug: paclitaxel Given IV
|
Active, not recruiting |
: Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
: - Fallopian Tube Cancer
- Ovarian Clear Cell Cystadenocarcinoma
: 2006-07-26
: - Biological: denileukin diftitox
|
Completed |
: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor
-
- Drug: TLR8 Agonist VTX-2337 Gi
|
Completed |
: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma
: - Brenner Tumor
- Fallopian Tube Cancer
- Ovarian Clear Cell
: 2003-05-06
: - Drug: paclitaxel Given IV
|
Active, not recruiting |
: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor
-
- Biological: Bevacizumab Given
|
Completed |
: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
: - Fallopian Tube Carcinoma
- Malignant Ovarian Mixed Epithelial Tumor
-
- Drug: Carboplatin Given IV
|
Recruiting |
: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
: - Ovarian Brenner Tumor
- Ovarian Carcinosarcoma
- Ovarian Clear
: 2014-03-28
: - Drug: Gemcitabine Hydrochloride
|
Suspended |
: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
: - Nausea and Vomiting
- Ovarian Brenner Tumor
- Ovarian Clear Ce
: 2011-01-11
: - Procedure: Adjuvant Therapy An
|